MedPath
NMPA Approval

DaShanZha Granules

国药准字Z13020112

June 22, 2020

Drug Information

大山楂颗粒

颗粒剂

每袋装15g

中药

June 22, 2020

Company Information

Applicant Company

Manufacturing Company

山东省巨野县振兴路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

大山楂颗粒 - NMPA 批准文号 | MedPath